Wai Chun Bio-Technology Ltd 2022 AR2
The report outlines the sustainability performance of Wai Chun Bio-Technology Limited for the eighteen months ended June 30, 2022. During this period, the company focused on its principal activity of manufacturing and selling modified starch and other biochemical products, primarily at its Shandong Factory. Key highlights include a significant increase in revenue to HK$1,007.19 million and the implementation of various environmental measures, such as treating all hazardous air emissions and sub-contracting waste treatment to licensed operators. The company also maintained its commitment to employee health and safety, reporting zero work-related fatalities.
Company: Wai Chun Bio-Technology Ltd
Sector: Consumer Staples
Country: Hong Kong
Year: 2022
Type: AR2
Pages: 125
Wai Chun Bio-Technology Ltd
Annual Report
The report outlines the sustainability performance of Wai Chun Bio-Technology Limited for the eighteen months ended June 30, 2022. During this period, the company focused on its principal activity of manufacturing and selling modified starch and other biochemical products, primarily at its Shandong Factory. Key highlights include a significant increase in revenue to HK$1,007.19 million and the implementation of various environmental measures, such as treating all hazardous air emissions and sub-contracting waste treatment to licensed operators. The company also maintained its commitment to employee health and safety, reporting zero work-related fatalities.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2021 - Jun 30, 2022
Fiscal Year
2022
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Workplace Fatalities
Employees